Infographic: 5 Key Biosimilars Terms Defined

At the AAM Biosimilar Council Conference 2017, Hillel Cohen, executive director of scientific affairs at Sandoz, disambiguated key terms in biosimilars.

Related Content:

AAM Biosimilars Council ConferenceConference

Data Show Promise for Adalimumab Biosimilars to Deliver on Safety, Cost Savings

Panelists Call for Consistent Education, Support to Improve Patient Comfort With Biosimilars

Cencora Analysis Shows Differences in Payer Coverage Between G-CSF Biosimilars